Literature DB >> 6893589

Haemagglutinating anti-actin antibodies in acute and chronic liver disease.

A N Hamlyn, P A Berg.   

Abstract

Anti-actin antibody was measured by the passive haemagglutination test in the serum of 118 patients with various forms of chronic cholestatic and non-cholestatic liver disease, and of 23 patients with acute hepatitis B or non-A, non-B. Tanned sheep erythrocytes and electrophoretically pure actin prepared from rabbit skeletal muscle were employed; absorption tests confirmed the specificity of positive reactions, defined from healthy controls as a titre of greater than 1/80. The presence of anti-actin activity in chronic liver disease corresponded generally to the immunofluorescent demonstration of smooth muscle antibody (P<0.01). However, in acute hepatitis, with one exception (later progressing to subacute disease) raised anti-actin titres were not found. Thus, the weak smooth muscle antibody occasionally demonstrable in this condition may be neither IgM in class, nor directed against actin. Anti-actin antibody was present in significantly high titre in 54% of 37 active chronic hepatitis patients and 79% of 24 ;mixed-form' cholestatic active chronic hepatitis, as compared with only 21% of 29 primary biliary cirrhosis patients, and 11% of alcoholic liver disease. Anti-actin antibody is therefore associated with chronic autoimmune parenchymal liver damage and its appearance may mark the transition from acute hepatitis. No raised anti-actin titres were seen in 10 primary biliary cirrhosis patients positive for mitochondrial antibody by indirect immunofluorescence, but negative by the complement fixation test. This result suggests that the cytoplasmic fluorescence observed is due to low titre mitochondrial antibody rather than cytoplasmic actin and that these patients do not represent a different disease entity. The generation of anti-actin antibody in chronic parenchymal liver disease, perhaps due to unmasking or schlepping of intracellular or SIg/HLA-associated actin, may characterise autoimmune events at hepatocyte level, point to prognosis, and aid in the differential diagnosis of individual patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6893589      PMCID: PMC1419614          DOI: 10.1136/gut.21.4.311

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

Review 1.  Immunopathology of liver disease.

Authors:  D Doniach; G Walker
Journal:  Prog Liver Dis       Date:  1972

2.  Immunofluorescent tracing of smooth muscle contractile protein antigens in tissues other than smooth muscle.

Authors:  P Trenchev; P Sneyd; E J Holborow
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

3.  Isolation of the monomeric subunit of immunoglobulin M with its interchain disulfide bonds intact.

Authors:  J E Morris; F P Inman
Journal:  Biochemistry       Date:  1968-08       Impact factor: 3.162

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

6.  An association between actin and the major histocompatibility antigen H-2.

Authors:  G L Koch; M J Smith
Journal:  Nature       Date:  1978-05-25       Impact factor: 49.962

7.  The amino acid sequence of Physarum actin.

Authors:  J Vandekerckhove; K Weber
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

8.  The primary structure of actin from rabbit skeletal muscle. Completion and analysis of the amino acid sequence.

Authors:  J H Collins; M Elzinga
Journal:  J Biol Chem       Date:  1975-08-10       Impact factor: 5.157

9.  [Heterogenicity of mitochondrial antibodies (author's transl)].

Authors:  P A Berg; T Binder; H Lindner; H Bannaski; D Maas; H Henning; H Brügel
Journal:  Dtsch Med Wochenschr       Date:  1975-05-16       Impact factor: 0.628

10.  Fixation of human anti-actin autoantibodies on skeletal muscle fibres.

Authors:  C Chaponnier; L Kohler; G Gabbiani
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

View more
  4 in total

1.  Sera with high levels of anti-smooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeleton proteins.

Authors:  G Dighiero; P Lymberi; C Monot; N Abuaf
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

2.  Liver cell membrane antibody detected by protein A and isolated rabbit liver plasma membrane in sera of patients with chronic liver diseases.

Authors:  G Toda; Y Ikeda; N Hashimoto; M Yamazaki; M Torii; H Oka
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

3.  Chronic active hepatitis in childhood with detection of liver-pancreas-specific autoantibodies.

Authors:  M Teufel; K H Niessen; P A Berg
Journal:  Eur J Pediatr       Date:  1983-03       Impact factor: 3.183

4.  Actin is a target of T-cell reactivity in patients with advanced carotid atherosclerotic plaques.

Authors:  Elisabetta Profumo; Brigitta Buttari; Linda Petrone; Giada Lacroce; Maria Chiara Tesori; Raffaele Capoano; Bruno Salvati; Rachele Riganò
Journal:  Mediators Inflamm       Date:  2013-11-11       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.